Alanine Transaminase

• 

  Subject Areas on Research

  • 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. 
  • 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. 
  • A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy. 
  • A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients. 
  • A pre-marketing ALT signal predicts post-marketing liver safety. 
  • AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study. 
  • Abnormal cardiac enzyme responses after strenuous exercise: alternative diagnostic aids. 
  • Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. 
  • Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. 
  • Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series. 
  • Acute pancreatitis and fulminant hepatic failure. 
  • Acute, subacute, and residual effects of polychlorinated biphenyl (pcb) in rats. II. Pathology and electron microscopy of liver and serum enzyme study. 
  • Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. 
  • Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage. 
  • Alanine Aminotransferase Results Differ by Analyzer Manufacturer in a National Integrated Health Setting, 2012-2017. 
  • Alterations in DNA methylation associate with fatty liver and metabolic abnormalities in a multi-ethnic cohort of pre-teenage children. 
  • Amoxicillin-Clavulanate-Induced Liver Injury. 
  • Analysis of injury in complex organ preservation. 
  • Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients. 
  • Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. 
  • Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection. 
  • Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers. 
  • Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa. 
  • Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. 
  • Capillary electrophoresis with electrochemiluminescence detection for measurement of aspartate aminotransferase and alanine aminotransferase activities in biofluids. 
  • Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis. 
  • Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B. 
  • Children's liver chemistries vary with age and gender and require customized pediatric reference ranges. 
  • Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency. 
  • Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials. 
  • Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. 
  • Clinical manifestations of congenital syphilitic hepatitis: implications for pathogenesis. 
  • Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C. 
  • Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. 
  • Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. 
  • Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. 
  • Current therapies for chronic hepatitis C. Drug combination achieves sustained response in more than half of patients. 
  • Cytokine storm of acute necrotizing encephalopathy. 
  • Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. 
  • Diabetes and prediabetes in patients with hepatitis B residing in North America. 
  • Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. 
  • Does this patient with liver disease have cirrhosis? 
  • Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. 
  • Drug rechallenge following drug-induced liver injury. 
  • Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial. 
  • Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. 
  • Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. 
  • Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity. 
  • Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy. 
  • Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials. 
  • Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. 
  • Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection. 
  • Frequency of Disparities in Laboratory Testing After Statin Initiation in Subjects ≥65 Years. 
  • Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes. 
  • Glutamine metabolism during aerial mycelium growth of Neurospora crassa. 
  • Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features. 
  • Glycogenic Hepatopathy Causing Elevated Lactic Acid and Liver Enzymes. 
  • Hepatitis C infection in children with hemophilia A and B. 
  • Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels. 
  • Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. 
  • Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis. 
  • Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration. 
  • Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury. 
  • In Reply. 
  • Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. 
  • Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. 
  • Intestinal Alkaline Phosphatase Attenuates Alcohol-Induced Hepatosteatosis in Mice. 
  • Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease. 
  • Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? 
  • Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. 
  • Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection. 
  • Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. 
  • Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV). 
  • Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin. 
  • Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. 
  • Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. 
  • Long-duration low-flow sevoflurane and isoflurane effects on postoperative renal and hepatic function. 
  • Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker. 
  • Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy. 
  • Marked transaminase elevation in anorexia nervosa. 
  • Mechanism of allyl formate-induced hepatotoxicity in rainbow trout. 
  • Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome. 
  • Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. 
  • Methylphenidate-induced autoimmune hepatitis. 
  • MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection. 
  • Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial. 
  • Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. 
  • Normal serum activities of some diagnostic enzymes in dromedary camel in Sudan. 
  • Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. 
  • Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction. 
  • Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury. 
  • Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas. 
  • Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. 
  • Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography. 
  • Preexposure prophylaxis for HIV infection among African women. 
  • Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort. 
  • Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. 
  • Protective effects of ischemic preconditioning on the cold-preserved liver are tyrosine kinase dependent. 
  • Relationship between pyridoxal 5'-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. 
  • Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. 
  • Risks of a range of alcohol intake on hepatitis C-related fibrosis. 
  • Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I). 
  • Serum aminotransferase changes with significant weight loss: sex and age effects. 
  • Serum enzyme alterations after extensive surgical procedures. 
  • Serum hepatic enzyme and bilirubin elevations during parenteral nutrition. 
  • Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects. 
  • Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys. 
  • Side effects suspected to be related to doxycycline use in cats. 
  • Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. 
  • Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network. 
  • Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3. 
  • The effect of protein nutrition on host and tumor metabolism. 
  • The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers. 
  • The effects of hepatic cryosurgery on tumor growth in the liver. 
  • The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. 
  • The prevalence and etiology of elevated aminotransferase levels in the United States. 
  • The relationship between hepatitis B surface antigen and antibody and continued drug use in narcotic dependency: a randomized controlled study. 
  • The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine. 
  • The toxic effects of Tephrosia apollinea on goats. 
  • Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. 
  • Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity. 
  • Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis. 
  • Whole body hyperthermia and heat-sensitizing drugs: a pilot study in canine lymphoproliferative disease. 
  • [Idiophatic inflammatory myophaties: its asociation with liver disorders]. 
  • [Systemic manifestations of myasthenia gravis and its putative pathogenesis].